France· FR:67178992
PHESGO 1200 mg/600 mg, solution injectable
A medicinal product containing pertuzumab + trastuzumab, registered in France by ROCHE REGISTRATION (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PERTUZUMAB + TRASTUZUMAB
- Manufacturer
- ROCHE REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550790261 flacon(s) en verre de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab + trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPHESGO 1200 MG/600 MG SOLUCION INYECTABLERoche Registration Gmbh
- FinlandPhesgoAbacus Medicine A/S
- CanadaPERJETA-HERCEPTINHOFFMANN-LA ROCHE LIMITED
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IrelandPhesgo 1200 mg/600 mg solution for injectionRoche Registration GmbH
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
- NorwayPhesgoRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
- Norway · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd80db63-5b98-49e5-a58c-021961eee139 GET /v1/drugs/cd80db63-5b98-49e5-a58c-021961eee139?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67178992",
"date_amm": "2020-12-21",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1497",
"substance": "PERTUZUMAB + TRASTUZUMAB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about pertuzumab + trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.